Finance

Lists
Why is AAPG up 11,75%?
Dive Deeper
AAPG:NASDAQ
Ascentage Pharma Group Internatinl - ADR
15,07 $
+11,75%
(+1,58) 1D
4 նոյ, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AAPG...
Open
14,44 $
High
15,50 $
Low
14,44 $
Mkt. cap
1,41 մլրդ
Avg. vol.
7,56 հզր
Volume
19,65 հզր
52-wk high
34,50 $
52-wk low
13,46 $
EPS
-2,37 $
Shares outstanding
93,74 մլն
No. of employees
828
Open
14,44 $
High
15,50 $
Low
14,44 $
Mkt. cap
1,41 մլրդ
Avg. vol.
7,56 հզր
Volume
19,65 հզր
52-wk high
34,50 $
52-wk low
13,46 $
EPS
-2,37 $
Shares outstanding
93,74 մլն
No. of employees
828
News stories
From web sources and news partners
About Ascentage Pharma Group Internatinl - ADR
CEODajun Yang
Employees828
Founded2009
Headquarters-
Sector-
Industry-
Analyst ratings
Based on 7 analysts giving stock ratings to AAPG in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AAPG in the last 3 months.
Highest
Current 15,07 $
48,00 $ (+218,51%)
Average
42,00 $ (+178,70%)
Lowest
33,00 $ (+118,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Initiated
46,00 $
+205,2%
10/15/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
35,00 $
+132,2%
10/13/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
33,00 $
+119%
10/08/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
45,00 $
+198,6%
09/02/2026
Jeet Mukherjee
BTIG
Buy
Maintained
48,00 $
+218,5%
08/20/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
08/21/2026
Jeff Jones
Oppenheimer
Buy
Maintained
45,00 $
+198,6%
08/21/2026
Biren Amin
Piper Sandler
Buy
Maintained
48,00 $
+218,5%
06/01/2026
James Shin
Deutsche Bank
Buy
Initiated
40,00 $
+165,4%
04/24/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
45,00 $
+198,6%
03/27/2026
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
170,21 մլն
170,21 մլն
151,11 մլն
151,11 մլն
Cost of goods sold
13,64 մլն
13,64 մլն
5,86 մլն
5,86 մլն
Cost of revenue
13,64 մլն
13,64 մլն
5,86 մլն
5,86 մլն
Research and development expenses
304,44 մլն
304,44 մլն
348,73 մլն
348,73 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181,22 մլն
181,22 մլն
172,64 մլն
172,64 մլն
Operating expense
485,67 մլն
485,67 մլն
521,37 մլն
521,37 մլն
Total operating expenses
499,31 մլն
499,31 մլն
527,23 մլն
527,23 մլն
Operating income
-329,10 մլն
-329,10 մլն
-376,13 մլն
-376,13 մլն
Other non operating income
-2,99 մլն
-2,99 մլն
-30,14 մլն
-30,14 մլն
EBT including unusual items
-325,37 մլն
-325,37 մլն
-401,69 մլն
-401,69 մլն
EBT excluding unusual items
-324,79 մլն
-324,79 մլն
-401,69 մլն
-401,69 մլն
Income tax expense
714,00 հզր
714,00 հզր
6,81 մլն
6,81 մլն
Effective tax rate
-0,22%
-0,22%
-1,70%
-1,70%
Other operating expenses
-
-
-
-
Net income
-326,00 մլն
-326,00 մլն
-408,35 մլն
-408,35 մլն
Net profit margin
-191,53%
-191,53%
-270,24%
-270,24%
Earnings per share
-
-
-
-
Interest and investment income
25,36 մլն
25,36 մլն
18,00 մլն
18,00 մլն
Interest expense
-13,14 մլն
-13,14 մլն
-13,41 մլն
-13,41 մլն
Net interest expenses
12,22 մլն
12,22 մլն
4,59 մլն
4,59 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-310,96 մլն
-310,96 մլն
-356,97 մլն
-356,97 մլն
Gain or loss from assets sale
-333,50 հզր
-333,50 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps